Pricing Log in Create free account
Friday 6 November 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

63.44 0.98 −1.52%
Market cap
$12.1B
P/E
21.7×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

The Cooper Companies, Inc. 8-K filed Oct 27, 2026

Period ended Oct 27, 2026 · Filed · accepted 4:36 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

What it says

CooperCompanies reported that Albert G. White III resigned as President, CEO and director on October 27, 2026; Walt Rosebrough became interim Executive Chair while the Board searches for a permanent CEO. White will advise through April 1, 2027. Shlomo Nachman will join the Board December 8, and three directors will not seek reelection in 2027. The company also reaffirmed fiscal 2026 guidance.

  • White will receive employment-agreement payments and benefits; the company expects additional transition-advisor compensation, with terms not yet determined.

    Mr. White has agreed to remain employed full time as a strategic advisor to the Company through April 1, 2027 to assist in the transition of his responsibilities. — the 8-K

  • Rosebrough was appointed Executive Chair on an interim basis, and the CEO Search Committee comprises Lawrence E. Kurzius, Cynthia L. Lucchese and Teresa S. Madden.

    Mr. Rosebrough will assume direct oversight of day-to-day operations at the Company until a permanent CEO is appointed. — the exhibit filed with it

  • Nachman was appointed as an independent director effective December 8, 2026; Barbara Carbone, Colleen E. Jay and Robert S. Weiss will remain directors until the 2027 Annual Meeting but will not stand for reelection.

    Shlomo Nachman was appointed to the Board, effective December 8, 2026, to serve until the Company’s 2027 Annual Meeting of Stockholders — the 8-K

  • The Board intends to reduce its size to seven directors following the 2027 Annual Meeting.

    The Company reaffirms the fiscal year 2026 guidance provided on September 9, 2026. — the exhibit filed with it

Red flags